Repository logo
 

Inflammation in Mild Cognitive Impairment due to Parkinson’s disease, Lewy Body disease and Alzheimer’s disease

Accepted version
Peer-reviewed

Loading...
Thumbnail Image

Type

Article

Change log

Authors

Williams-Gray, Caroline  ORCID logo  https://orcid.org/0000-0002-2648-9743

Abstract

Background Abstract Inflammation appears to play a role in the progression of neurodegenerative diseases. However, little is known about inflammation during early stages of cognitive decline or whether this differs in different disease groups. We sought to investigate this by assessing the inflammatory profile in patients with Parkinson’s disease with the early stages of cognitive impairment (PD-MCI), patients with prodromal Alzheimer’s disease (MCI-AD), prodromal Lewy Body disease (MCI-LB) and controls. Methods We obtained venous blood samples from participants with PD-MCI (n = 44), PD-normal cognition (n = 112) MCI-LB (n = 38), MCI-AD (n = 21) and controls (n = 84). We measured 10 cytokines using Meso Scale Discovery V-Plex Plus including interferon-gamma, interleukin (IL)-10, IL-12p70, IL-13, IL-1beta, IL- 2, IL-4, IL-6, IL-8 and tumour necrosis factor alpha. High-sensitivity C–reactive protein was measured. Results There was a higher level of inflammation in patients with MCI-AD and MCI-LB compared with controls. PD non-cognitively impaired had higher inflammatory markers than controls but there was no difference between PD-MCI and controls. There was a decrease in inflammatory markers with increasing motor severity based on the Unified Parkinson’s Disease Rating Scale. Conclusions Inflammation may be involved in the onset of cognitive decline in patients with MCI-AD and MCI-LB but appears to be less prominent PD-MCI albeit in a small data set. This suggests that anti- inflammatory medications may have most benefit at the earliest stages of neurodegenerative diseases. For PD cases, this might be in advance of the development of MCI.

Description

Keywords

Alzheimer disease, Dementia, Inflammation, Lewy body disease, Mild cognitive impairment, Parkinson disease, Aged, Aged, 80 and over, Alzheimer Disease, Biomarkers, C-Reactive Protein, Case-Control Studies, Cognitive Dysfunction, Cytokines, Disease Progression, Female, Humans, Inflammation, Interleukin-1beta, Lewy Body Disease, Male, Middle Aged, Neuropsychological Tests, Parkinson Disease

Journal Title

International Journal of Geriatric Psychiatry

Conference Name

Journal ISSN

1099-1166
1099-1166

Volume Title

Publisher

John Wiley & Sons Inc.

Rights

All rights reserved
Sponsorship
Medical Research Council (MR/R007446/1)
The LewyPro work was funded by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre in Lewy Body Dementia based at Newcastle upon Tyne NHS Foundation Trust and Newcastle University and The Royal College of Psychiatrists Pathfinder Fellowship. ICICLE-PD was funded by Parkinson’s UK (J-0802, G-1507). The research was supported by the Lockhart Parkinson’s Disease Research Fund, the academy of Medical Sciences UK, the Rosetrees Trust, and the Stevenage Biosciences Catalyst, the National Institute for Health Research (NIHR) Newcastle Biomedical Research Unit based at Newcastle Upon Tyne Hospitals NHS Foundation Trust and Newcastle University and the NIHR Cambridge Biomedical Research Centre. CWG is supported by a Clinician Scientist Fellowship from the MRC.